1. Home
  2. OBIO vs PMM Comparison

OBIO vs PMM Comparison

Compare OBIO & PMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OBIO
  • PMM
  • Stock Information
  • Founded
  • OBIO 2017
  • PMM 1989
  • Country
  • OBIO United States
  • PMM United States
  • Employees
  • OBIO N/A
  • PMM N/A
  • Industry
  • OBIO Medicinal Chemicals and Botanical Products
  • PMM Investment Managers
  • Sector
  • OBIO Health Care
  • PMM Finance
  • Exchange
  • OBIO Nasdaq
  • PMM Nasdaq
  • Market Cap
  • OBIO 291.7M
  • PMM 283.6M
  • IPO Year
  • OBIO N/A
  • PMM N/A
  • Fundamental
  • Price
  • OBIO $8.51
  • PMM $6.21
  • Analyst Decision
  • OBIO Strong Buy
  • PMM
  • Analyst Count
  • OBIO 2
  • PMM 0
  • Target Price
  • OBIO $17.00
  • PMM N/A
  • AVG Volume (30 Days)
  • OBIO 248.5K
  • PMM 118.3K
  • Earning Date
  • OBIO 08-08-2024
  • PMM 01-01-0001
  • Dividend Yield
  • OBIO N/A
  • PMM 4.68%
  • EPS Growth
  • OBIO N/A
  • PMM N/A
  • EPS
  • OBIO N/A
  • PMM 0.23
  • Revenue
  • OBIO $2,216,000.00
  • PMM N/A
  • Revenue This Year
  • OBIO $17.90
  • PMM N/A
  • Revenue Next Year
  • OBIO $10.51
  • PMM N/A
  • P/E Ratio
  • OBIO N/A
  • PMM $26.52
  • Revenue Growth
  • OBIO N/A
  • PMM N/A
  • 52 Week Low
  • OBIO $4.22
  • PMM $5.00
  • 52 Week High
  • OBIO $11.69
  • PMM $6.42
  • Technical
  • Relative Strength Index (RSI)
  • OBIO 62.57
  • PMM 58.13
  • Support Level
  • OBIO $7.48
  • PMM $6.18
  • Resistance Level
  • OBIO $8.20
  • PMM $6.24
  • Average True Range (ATR)
  • OBIO 0.60
  • PMM 0.06
  • MACD
  • OBIO 0.04
  • PMM -0.00
  • Stochastic Oscillator
  • OBIO 89.59
  • PMM 75.00

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.

About PMM Putnam Managed Municipal Income Trust

Putnam Managed Municipal Income Trust is a closed-end management investment company. Its investment objective is to seek a high level of current income exempt from federal income tax by investing in a diversified portfolio of tax-exempt municipal securities. The Fund invests in various sectors such as healthcare, retirement community, private higher education, housing-backed, essential service utilities, and state-backed bonds.

Share on Social Networks: